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Abstract 
Review on MAPK6, with data on DNA, on the 
protein encoded, and where the gene is implicated. 
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Identity 
HGNC (Hugo) 
MAPK6 
Location 
15q21.2 
Other names 
ERK3, PRKM6, p97MAPK 
Local order 
The MAPK6 gene is located between the genes 
LEO1 and BCL2L10 on chromosome 15. 
DNA/RNA 
Genomic organization of the MAPK6 gene on chromosome 15. 
Description 
The MAPK6 gene spans 47.01 kb on the long arm of 
chromosome 15 and is transcribed in the centromere-
to-telomere orientation. The gene is composed of 6 
exons with the translation initiation codon located in 
exon 2. The first two exons are separated by a long 
intron of 26.45 kb. 
Transcription 
The MAPK6 transcribed mRNA has 4,186 bp. No 
splice variants have been reported. 
Pseudogene 
Database analysis reveals the presence of six 
MAPK6 pseudogenes localized on four different 
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chromosomes: MAPK6PS1 (8q11.23), MAPK6PS2 
(21q21.1), MAPK6PS3 (13q14.13), MAPK6PS4 
(8q11.1), MAPK6PS5 (8q23.1) and MAPK6PS6 
(10q11.23). All six loci contain intronless copies of 
MAPK6 and display the features of processed 
pseudogenes. 
Protein 
 
Schematic representation of the ERK3 protein structure. Kinase, catalytic kinase domain; C34 conserved region 
in ERK3 and ERK4; SEG, activation loop motif containing the regulatory phosphorylation residue Ser189. 
Description 
Extracellular signal-regulated kinase 3 (ERK3) is an 
atypical member of the mitogen-activated protein 
(MAP) kinase family of serine/threonine kinases. 
The human ERK3 protein is made of 721 amino 
acids and contains a typical kinase domain located at 
the N-terminal extremity. Another region with 
homology to the MAP kinase ERK4 (C34 domain) 
has been identified after the kinase domain. The 
function of the C34 domain is unknown. 
Expression 
MAPK6 mRNA is expressed ubiquitously. The 
highest levels of expression are observed in the 
skeletal muscle and brain. ERK3 is a highly unstable 
protein, with a half-life of less than one hour, that is 
constitutively degraded by the ubiquitin-proteasome 
pathway. 
Localisation 
ERK3 localizes to the cytoplasm and nucleus of a 
variety of cultured cells. 
Function 
Little is known about the regulation and functions of 
ERK3. Recent studies suggest a potential 
involvement of the kinase in the control of cell 
differentiation, cytoskeletal remodelling, cell 
migration and invasion, DNA repair, and immune 
response. The best-characterized and validated 
substrate of ERK3 is the protein kinase MAPKAPK5 
(MK5). 
Homology 
ERK3 display 73% amino acid identity with ERK4 
in the kinase domain. ERK4 and ERK3 define a 
distinct subfamily of MAP kinases. 
Mutations 
No recurrent mutation in the MAPK6 gene has been 
reported in cancer. 
Implicated in 
Cancer 
Studies have documented the upregulation of 
MAPK6 mRNA in squamous cell carcinomas of the 
skin, squamous cell lung carcinoma, and tongue 
squamous cell carcinoma. Expression of MAPK6 
mRNA is also increased in salivary adenoid cystic 
carcinoma, adrenocortical carcinoma, T-cell acute 
lymphoblastic leukemia, and acute myeloid 
leukemia. In lymphomas, reports have suggested an  
 
increase of MAPK6 expression in Burkitt's 
lymphoma and a decrease in Hodgkin's lymphoma. 
Downregulation of MAPK6 mRNA level has also 
been observed in cutaneous melanoma, (colorectal 
adenocarcinomaand esophageal adenocarcinoma. 
The significance of these changes remains to be 
investigated. 
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